TETRASUBSTITUTED ALKENE COMPOUNDS AND THEIR USE

Disclosed herein are compounds, or pharmaceutically acceptable salts thereof, and methods of using the compounds for treating breast cancer by administration to a subject in need thereof a therapeutically effective amount of the compounds or pharmaceutically acceptable salts thereof. The breast canc...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	HAO, Ming-Hong, PUYANG, Xiaoling, KORPAL, Manav, NYAVANANDI, Vijay Kumar, BOCK, Mark
Format:	Patent
Sprache:	eng ; hun
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS METALLURGY ORGANIC CHEMISTRY
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page
container_issue
container_start_page
container_title
container_volume
creator	HAO, Ming-Hong PUYANG, Xiaoling KORPAL, Manav NYAVANANDI, Vijay Kumar BOCK, Mark
description	Disclosed herein are compounds, or pharmaceutically acceptable salts thereof, and methods of using the compounds for treating breast cancer by administration to a subject in need thereof a therapeutically effective amount of the compounds or pharmaceutically acceptable salts thereof. The breast cancer may be an ER-positive breast cancer and/or the subject in need of treatment may express a mutant ER-α protein.
format	Patent
fullrecord	<record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_HUE056199TT2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>HUE056199TT2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_HUE056199TT23</originalsourceid><addsrcrecordid>eNrjZNAPcQ0JcgwOdQoO8QwJDXF1UXD08Xb1c1Vw9vcN8A_1cwlWcPRzUQjxcPUMUggNduVhYE1LzClO5YXS3AyKbq4hzh66qQX58anFBYnJqXmpJfEeoa4GpmaGlpYhIUbGxKgBADpmJuo</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>TETRASUBSTITUTED ALKENE COMPOUNDS AND THEIR USE</title><source>esp@cenet</source><creator>HAO, Ming-Hong ; PUYANG, Xiaoling ; KORPAL, Manav ; NYAVANANDI, Vijay Kumar ; BOCK, Mark</creator><creatorcontrib>HAO, Ming-Hong ; PUYANG, Xiaoling ; KORPAL, Manav ; NYAVANANDI, Vijay Kumar ; BOCK, Mark</creatorcontrib><description>Disclosed herein are compounds, or pharmaceutically acceptable salts thereof, and methods of using the compounds for treating breast cancer by administration to a subject in need thereof a therapeutically effective amount of the compounds or pharmaceutically acceptable salts thereof. The breast cancer may be an ER-positive breast cancer and/or the subject in need of treatment may express a mutant ER-α protein.</description><language>eng ; hun</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; METALLURGY ; ORGANIC CHEMISTRY</subject><creationdate>2022</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220128&DB=EPODOC&CC=HU&NR=E056199T2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,777,882,25545,76296</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220128&DB=EPODOC&CC=HU&NR=E056199T2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>HAO, Ming-Hong</creatorcontrib><creatorcontrib>PUYANG, Xiaoling</creatorcontrib><creatorcontrib>KORPAL, Manav</creatorcontrib><creatorcontrib>NYAVANANDI, Vijay Kumar</creatorcontrib><creatorcontrib>BOCK, Mark</creatorcontrib><title>TETRASUBSTITUTED ALKENE COMPOUNDS AND THEIR USE</title><description>Disclosed herein are compounds, or pharmaceutically acceptable salts thereof, and methods of using the compounds for treating breast cancer by administration to a subject in need thereof a therapeutically effective amount of the compounds or pharmaceutically acceptable salts thereof. The breast cancer may be an ER-positive breast cancer and/or the subject in need of treatment may express a mutant ER-α protein.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2022</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNAPcQ0JcgwOdQoO8QwJDXF1UXD08Xb1c1Vw9vcN8A_1cwlWcPRzUQjxcPUMUggNduVhYE1LzClO5YXS3AyKbq4hzh66qQX58anFBYnJqXmpJfEeoa4GpmaGlpYhIUbGxKgBADpmJuo</recordid><startdate>20220128</startdate><enddate>20220128</enddate><creator>HAO, Ming-Hong</creator><creator>PUYANG, Xiaoling</creator><creator>KORPAL, Manav</creator><creator>NYAVANANDI, Vijay Kumar</creator><creator>BOCK, Mark</creator><scope>EVB</scope></search><sort><creationdate>20220128</creationdate><title>TETRASUBSTITUTED ALKENE COMPOUNDS AND THEIR USE</title><author>HAO, Ming-Hong ; PUYANG, Xiaoling ; KORPAL, Manav ; NYAVANANDI, Vijay Kumar ; BOCK, Mark</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_HUE056199TT23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; hun</language><creationdate>2022</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><toplevel>online_resources</toplevel><creatorcontrib>HAO, Ming-Hong</creatorcontrib><creatorcontrib>PUYANG, Xiaoling</creatorcontrib><creatorcontrib>KORPAL, Manav</creatorcontrib><creatorcontrib>NYAVANANDI, Vijay Kumar</creatorcontrib><creatorcontrib>BOCK, Mark</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>HAO, Ming-Hong</au><au>PUYANG, Xiaoling</au><au>KORPAL, Manav</au><au>NYAVANANDI, Vijay Kumar</au><au>BOCK, Mark</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>TETRASUBSTITUTED ALKENE COMPOUNDS AND THEIR USE</title><date>2022-01-28</date><risdate>2022</risdate><abstract>Disclosed herein are compounds, or pharmaceutically acceptable salts thereof, and methods of using the compounds for treating breast cancer by administration to a subject in need thereof a therapeutically effective amount of the compounds or pharmaceutically acceptable salts thereof. The breast cancer may be an ER-positive breast cancer and/or the subject in need of treatment may express a mutant ER-α protein.</abstract><oa>free_for_read</oa></addata></record>
fulltext	fulltext_linktorsrc
identifier
ispartof
issn
language	eng ; hun
recordid	cdi_epo_espacenet_HUE056199TT2
source	esp@cenet
subjects	CHEMISTRY HETEROCYCLIC COMPOUNDS METALLURGY ORGANIC CHEMISTRY
title	TETRASUBSTITUTED ALKENE COMPOUNDS AND THEIR USE
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T18%3A38%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=HAO,%20Ming-Hong&rft.date=2022-01-28&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EHUE056199TT2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true